Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report
Immunotherapy has become an integral part of a comprehensive treatment approach to metastatic colorectal cancer (mCRC). Nivolumab (Opdivo) is a human immunoglobulin G4 monoclonal antibody that blocks the interaction between the programmed cell death 1 (PD-1) receptor and its ligands 1/2 (PD-L1/PD-L2...
Saved in:
Main Authors: | Nataliya Babyshkina (Author), Nataliya Popova (Author), Evgeny Grigoryev (Author), Tatyana Dronova (Author), Polina Gervas (Author), Alexey Dobrodeev (Author), Dmitry Kostromitskiy (Author), Victor Goldberg (Author), Sergei Afanasiev (Author), Nadejda Cherdyntseva (Author) |
---|---|
Format: | Book |
Published: |
AboutScience Srl,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
by: А. E. Protasova, et al.
Published: (2024) -
Microsatellite Markers
Published: (2016) -
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
by: Marcos Oro-Ayude, et al.
Published: (2020) -
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
by: Nanumi Han, et al.
Published: (2018) -
Microsatellites in varied arenas of research
by: K S Remya, et al.
Published: (2010)